🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of the efficacy, safety, and tolerability of serlopitant for the trea...
Status
Completed
Location
Study Site 130
Start Date
2017-10-03
Trial ID
NCT03282591
Treatments Being Tested
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safet...
Status
Completed
Location
Study Site 221
Start Date
2019-01-22
Trial ID
NCT03841331
Treatments Being Tested
Study of the efficacy, safety, and tolerability of serlopitant for the trea...
Status
Completed
Location
Study Site 504
Start Date
2018-05-02
Trial ID
NCT03546816
Treatments Being Tested
A study of a several doses of a novel treatment for chronic itch compared t...
Status
Completed
Location
Center for Dermatology Clinical Research, Inc.
Start Date
2013-10-15
Trial ID
NCT01951274
To determine if Serlopitant (when taken by mouth) is safe and works on itch...
Status
Completed
Location
Stanford University
Start Date
2019-04-18
Trial ID
NCT03836001
Treatments Being Tested
Study of the long term safety of serlopitant for the treatment of pruritus ...
Status
Terminated
Location
Study Site 504
Start Date
2018-03-15
Trial ID
NCT03540160
Treatments Being Tested
Study of the efficacy, safety, and tolerability of serlopitant for the trea...
Status
Completed
Location
Study Site 221
Start Date
2017-11-01
Trial ID
NCT03343639
Treatments Being Tested
Our goal is to determine whether daily oral administration of VPD-737 (5 mg...
Status
Completed
Location
Stanford
Start Date
2016-08-31
Trial ID
NCT02654483
The purpose of this study is to demonstrate whether or not VPD-737, an NK1 ...
Status
Completed
Location
Study Site 08
Start Date
2014-07-09
Trial ID
NCT02196324
Treatments Being Tested
Study of the efficacy, safety, and tolerability of serlopitant for the trea...
Status
Completed
Location
Study Site 649
Start Date
2018-08-29
Trial ID
NCT03677401
Treatments Being Tested